The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
about
Role of intrinsic airway neurons in ozone-induced airway hyperresponsiveness in ferret tracheaInterleukin-1ß-induced airway hyperresponsiveness enhances substance P in intrinsic neurons of ferret airwayThe involvement of TRPV1 in emesis and anti-emesisIntegration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sicknessIdentification of neural networks that contribute to motion sickness through principal components analysis of fos labeling induced by galvanic vestibular stimulationFosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomitingSafety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in catsDrug insight: New antiemetics in the management of chemotherapy-induced nausea and vomitingA study of tolerance to apomorphineSynthetic and natural antioxidants attenuate cisplatin-induced vomitingFundamentals of neurogastroenterologyInduction of emetic, pyrexic, and behavioral effects of Staphylococcus aureus enterotoxin B in the ferretPhase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.Anti-emetics in development.Oral and pharyngeal reflexes in the mammalian nervous system: their diverse range in complexity and the pivotal role of the tongue.The effect of CP-99994 on the responses to provocative motion in the cat.Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist.The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew.Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews.The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.Aprepitant (EMEND): the role of substance P in nausea and vomiting.Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy.Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitantNeurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.Opportunities for the replacement of animals in the study of nausea and vomitingReceptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditionsTachykinins and their receptors: contributions to physiological control and the mechanisms of disease.A tachykinin-like neuroendocrine signalling axis couples central serotonin action and nutrient sensing with peripheral lipid metabolism.Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonistsDevelopment of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signalingEfficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
P2860
Q23923224-03FA794B-22E2-40D9-9056-E95A6F2CA024Q23924176-D492A7BE-DFA7-45F3-BDA4-086603B31B08Q26745801-26AD291B-25DD-4747-A517-F74E820763D6Q26823866-968DB90E-E71A-4A4B-83A0-DA063233841FQ27329682-99D18B6E-0009-448D-9701-594A434D7A72Q28258863-8477E315-BD7F-4794-AB60-820D82DD64AAQ28279681-458B3818-875D-499F-BDF6-D8C5EF5FFC66Q28280032-227202B9-01BC-491E-BE3B-11A8592F02C7Q28379212-BE841EE7-522F-48E7-B0AC-6AEFF634B399Q30834914-673AEAFD-C017-4678-B050-A2A540DD912EQ33717379-1A9F04DF-675C-4394-89B8-51D423CA39DCQ34004088-F247A536-432C-473B-BF46-06599E0A15A5Q34458672-1408F4A0-4AF6-4A25-9249-FC45C3E6C32FQ34600063-DC2B707B-EB4F-4C2E-9D92-2DF6383769B8Q34660860-49874B85-524B-4CB8-BB74-E39E16DDFFD9Q34977322-D216BDD0-432F-4EF2-A242-3A601DB8316FQ35025358-E4C5A7D7-6ED2-47CE-9592-E5993F798594Q35027928-260C24E0-3F42-4B18-BF27-838C0C353EB3Q35042464-A3085C74-0B75-4F13-ADBC-1D4D02323A34Q35114037-1E1971A9-353A-4A94-A332-59208323E1CEQ35873107-5A3B1D03-0DD5-466D-AA62-158958296B25Q35964412-A878DCDD-9026-4C7F-B8A4-8DF3810E58F0Q36284018-43872A76-E8DF-4C31-A09D-A49A753936F5Q36400372-5CB0003C-9DC5-46A1-8534-B63697EDB761Q36793614-7631C0DF-20AF-467E-8D7C-68C65B29E6A2Q36823546-66A5A31B-A15C-44CE-A6E1-7EDF1AD10ADDQ36828595-89C0D060-5921-4298-81E6-085D1987C429Q37316977-45C6EF3E-2DCF-4304-8995-CFF5F65459F3Q37332618-BA2B2482-59F7-412F-8112-5703D3E506EEQ37407809-05589852-F4F8-4403-BDDF-20ECEDF845CDQ37492012-84A615F2-192B-49CB-A9C6-4F06AF6A3159Q37593097-E272EDCF-FD4C-4E32-A9CB-5C496487DC3CQ37622444-03FEDEA1-235A-47AE-93C0-0AF202126C40Q37761329-8C4C5049-461C-438E-8071-D26BCD0B703DQ37857329-0E629852-AD2C-4BF3-A570-CBFDA8A924C9Q38215005-6C27CD0F-873F-4630-8B53-B891B7019915Q38572037-CA17E929-B41D-4BD3-BA2C-7DFAA4C1CF36Q40978787-DDFE71E5-31A9-4E93-ADCB-B22C6015A57BQ41878959-426A65CE-7E8B-4099-A454-B3335779846CQ42106048-A1254226-D556-44A9-8D66-EE3FE5708940
P2860
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@ast
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@en
type
label
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@ast
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@en
prefLabel
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@ast
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@en
P2093
P2860
P1476
The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
@en
P2093
Andrews PL
Gonsalves SF
P2860
P356
10.1111/J.1476-5381.1995.TB16324.X
P407
P577
1995-05-01T00:00:00Z